Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Membranous Nephropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT00405340
What this trial is testing

Rituximab in the Treatment of Idiopathic Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Mayo Clinic 20
Large-scale testing (Phase 3)Looking for participantsNCT05696613
What this trial is testing

SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc. 148
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07029139
What this trial is testing

Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Shanghai JMT-Bio Inc. 156
Large-scale testing (Phase 3)Active Not RecruitingNCT04629248
What this trial is testing

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Hoffmann-La Roche 142
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Testing effectiveness (Phase 2)Ended earlyNCT01353638
What this trial is testing

Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis

Who this might be right for
End Stage Renal Disease
Christoph Aufricht 25
Post-approval studies (Phase 4)Study completedNCT00843856
What this trial is testing

Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis

Who this might be right for
Glomerulonephritis, Membranous
Imperial College Healthcare NHS Trust 40
Not applicableUnknownNCT05861869
What this trial is testing

Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)

Who this might be right for
Membranous Nephropathy - PLA2R InducedKidney Diseases-except Membranous Nephropathy
Zhejiang Biostar Biotechnology Co. 450
Not applicableStudy completedNCT07702981
What this trial is testing

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Who this might be right for
Membranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
University Hospital, Ioannina 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06642909
What this trial is testing

A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
BioRay Pharmaceutical Co., Ltd. 135
Very early researchStudy completedNCT00047983
What this trial is testing

Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients

Who this might be right for
Kidney Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 75
Not applicableNot Yet RecruitingNCT07416942
What this trial is testing

Omics of Rituximab-resistance

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Not applicableStudy completedNCT05788211
What this trial is testing

REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)

Who this might be right for
Cardiogenic ShockRenal Replacement TherapyVenoarterial Extracorporeal Membrane Oxygenation
University Hospital, Bordeaux 93
Not applicableStudy completedNCT02694068
What this trial is testing

Biological Determinants of Peritoneal Dialysis

Who this might be right for
End-Stage Kidney Disease
University of Washington 4,865
Post-approval studies (Phase 4)Study completedNCT04424862
What this trial is testing

Multitarget Therapy for Idiopathic Membranous Nephropathy

Who this might be right for
Efficacy
Beijing Friendship Hospital 82
Not applicableNot Yet RecruitingNCT07806708
What this trial is testing

DKK3 as a Biomarker of Peritoneal Fibrosis in Peritoneal Dialysis Patients

Who this might be right for
Peritoneal Dialysis (PD)End Stage Renal Disease (ESRD)Peritoneal Fibrosis+1 more
Universität des Saarlandes 30
Not applicableStudy completedNCT07836881
What this trial is testing

Effects of Supervised Exercise Training on Erythrocyte Deformability in Hemodialysis Patients

Who this might be right for
End-Stage Renal Disease Requiring Haemodialysis
Asia University 63
Not applicableUnknownNCT03169400
What this trial is testing

Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)

Who this might be right for
End Stage Renal Failure on DialysisVascular CalcificationOxidative Stress
University of Milan 20
Large-scale testing (Phase 3)Study completedNCT01508468
What this trial is testing

Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Assistance Publique - Hôpitaux de Paris 80
Next Page